The Effect of Rehabilitative Games With SmartPose on Upper Extremity Recovery in Stroke Patients

January 20, 2026 updated by: Cilen Tavsanoglu, Istanbul University - Cerrahpasa

The Effect of Rehabilitative Games With SmartPose Practice on Upper Extremity Recovery in Ischemic Stroke Patients

The goal of this clinical trial is to investigate the effects of SmartPose games on upper extremity motor, functional, and sensory recovery in patients with stroke. The main question it aims to answer is:

  • Does the use of rehabilitative games with the SmartPose application work to treat upper extremity motor, functional, and sensory recovery in stroke patients?

Researchers will compare the experimental group with the control group, which receives only conventional exercises with proven effectiveness, to determine whether SmartPose has an effect on upper extremity motor, functional, and sensory recovery in stroke patients.

The experimental group will receive 30 minutes of neuromuscular therapy and 30 minutes of SmartPose, 3 times a week for 8 weeks.

The control group will receive 60 minutes of neuromuscular therapy, 3 times a week for 8 weeks.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
      • Istanbul, Turkey (Türkiye)
        • Istanbul University-Cerrahpaşa, Faculty of Health Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Mini Mental State Examination score ≥ 24
  • Age between 35 and 75 years
  • Medical condition sufficiently stable to allow participation in active rehabilitation
  • Brunnstrom Upper Extremity Stage ≥ 3
  • Minimum sixth week post-stroke
  • Ability to perform shoulder abduction and flexion against gravity with a minimum of 20°

Exclusion Criteria:

  • Presence of secondary impairments affecting upper extremity movement
  • Modified Ashworth Scale score of 4 or 5
  • Inability to maintain independent sitting balance
  • Visual impairment or loss that prevents the perception of visual materials

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
A one-hour exercise protocol will be administered in this group, consisting of 30 minutes of conventional exercises and 30 minutes of Smartpose exercises.
Other: Exercise
Personalized neuromuscular exercises, according to the patient's specific needs.
Other Names:
  • Rehabilitation
Other: SmartPose
Virtual reality application containing rehabilitative games developed for individuals in need of exercise.
Other Names:
  • Virtual Reality
  • Exergame
Active Comparator: Control
A one-hour conventional exercise program will be administered to this group.
Other: Exercise
Personalized neuromuscular exercises, according to the patient's specific needs.
Other Names:
  • Rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Fugl-Meyer Assessment of Motor Recovery after Stroke - Upper Limb
Time Frame: Baseline and 8 weeks
Fugl-Meyer is the first measure developed to quantitatively assess sensorimotor recovery after stroke. In our study, to evaluate total sensorimotor recovery, we used the motor function section of this assessment, which consists of 33 items and a total of 66 points, and the sections on sensation, passive joint movement, and joint pain, which have a total of 60 points. Higher scores reflect better motor function recovery.
Baseline and 8 weeks
Frenchay Arm Test
Time Frame: Baseline and 8 weeks
FAT assesses motor control and hand skills in patients with functional loss in the upper extremity following neurological impairment. The test consists of 5 items and takes a total of 3 minutes. Each item is scored as successful (1 point) or unsuccessful (0 points). It is evaluated on a total of 5 points. Higher scores reflect better motor control.
Baseline and 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Ashworth Scale
Time Frame: Baseline and 8 weeks
MAS is a scale developed to assess muscle tone by determining the resistance exhibited against passive movement throughout the range of motion in the joint, and its validity has been proven in cases of stroke. The Modified Ashworth Scale (MAS) consists of six categories: 0, 1, 1+, 2, 3, and 4 (with the addition of 1+). Scoring is based on the resistance felt during passive movement of the joint, where 0 indicates no increase in muscle tone and 4 indicates a rigid joint. Lower scores reflect a lower degree of spasticity.
Baseline and 8 weeks
Brunnstrom Stages of Stroke Recovery
Time Frame: Baseline and 8 weeks
Brunnstrom is an approach that can be used both as a treatment approach and to assess body functions in cases of stroke. The Brunnstrom staging system has created a common language in the rehabilitation process. Higher stages indicate closer approximation to normal motor function.
Baseline and 8 weeks
Box and Block Test
Time Frame: Baseline and 8 weeks
BBT is a measure that evaluates manual dexterity based on performance. The patient was asked to move as many cubes as possible from the box in front of them to the other box next to them using the affected extremity for 60 seconds. A higher number of transferred cubes indicates better hand performance.
Baseline and 8 weeks
Functional Independence Measure
Time Frame: Baseline and 8 weeks
The FIM is used to assess patients' functional status and level of independence. The test consists of two sections; motor skills and cognitive skills. Scores range from 18, indicating complete dependence, to 126, indicating full independence.
Baseline and 8 weeks
Stroke Specific Quality of Life Scale
Time Frame: Baseline and 8 weeks
The Stroke-Specific Quality of Life Scale was developed to assess quality of life parameters in stroke patients. The scale consists of a total of 48 items and 8 subscales. The items of the Stroke-Specific Quality of Life Scale are rated on a 5-point scale ranging from 1 to 5. The response options are scored as '1 = strongly agree, 2 = partially agree, 3 = neutral, 4 = partially disagree, and 5 = strongly disagree.' For some items, the response options are scored as '1 = could not do at all, 2 = had great difficulty, 3 = had some difficulty, 4 = had little difficulty, and 5 = no difficulty.' Higher total scores indicate better quality of life.
Baseline and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul University - Cerrahpasa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 11, 2025

Primary Completion (Actual)

June 1, 2025

Study Completion (Actual)

June 1, 2025

Study Registration Dates

First Submitted

January 11, 2025

First Submitted That Met QC Criteria

January 11, 2025

First Posted (Actual)

January 16, 2025

Study Record Updates

Last Update Posted (Actual)

January 22, 2026

Last Update Submitted That Met QC Criteria

January 20, 2026

Last Verified

June 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Msc thesis

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe